Takeru Kashiwada, Ryotaro Takano, Fumihiko Ando, Shoko Kuroda, Yoshishige Miyabe, Ryuji Owada, Akihiko Miyanaga, Tomoko Asatsuma-Okumura, Masaaki Hashiguchi, Yoshikazu Kanazawa, et al. Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients. Frontiers in Pharmacology. 2024. 15
Fumihiko Ando, Takeru Kashiwada, Shoko Kuroda, Takenori Fujii, Ryotaro Takano, Yoshishige Miyabe, Shinobu Kunugi, Takashi Sakatani, Akihiko Miyanaga, Tomoko Asatsuma-Okumura, et al. Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer. Frontiers in Pharmacology. 2024. 15
Joshua K Stone, Natalia von Muhlinen, Chenran Zhang, Ana I Robles, Amy L Flis, Eleazar Vega-Valle, Akihiko Miyanaga, Masaru Matsumoto, K Leigh Greathouse, Tomer Cooks, et al. Acidovorax temperans skews neutrophil maturation and polarizes Th17 cells to promote lung adenocarcinoma development. Oncogenesis. 2024. 13. 1. 13-13
Takehiro Tozuka, Rintaro Noro, Keisuke Yoshida, Satoshi Takahashi, Mariko Hirao, Kuniko Matsuda, Yasuhiro Kato, Shinji Nakamichi, Susumu Takeuchi, Masaru Matsumoto, et al. Phosphoproteomic Analysis Identified Mutual Phosphorylation of FAK and Src as a Mechanism of Osimertinib Resistance in EGFR-Mutant Lung Cancer. JTO clinical and research reports. 2024. 5. 4. 100668-100668
Yang Yunchu, Akihiko Miyanaga, Kuniko Matsuda, Koichiro Kamio, Masahiro Seike. Exploring effective biomarkers and potential immune related gene in small cell lung cancer. Scientific reports. 2024. 14. 1. 7604-7604
Internal Association for the Study of Lung Cancer
, American Association of Cancer Research
, 日本呼吸器内視鏡学会
, 日本肺癌学会
, 日本癌学会
, 日本癌治療学会
, 日本臨床腫瘍学会
, 日本呼吸器学会
, 日本内科学会